Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.490, 2005-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Insulin analogues worth the extra cost in type 1 DM
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :
Access to resources
Recommend
Insulin analogues worth the extra cost in type 1 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. :
Insulin therapy decreases long-term costs in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 426, 2003-01 ,pp. :
Insulin glargine superior long-term therapy for type 2 DM in Europe
Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. :
Insulin glargine superior long-term therapy in type 2 DM in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 462, 2004-01 ,pp. :